Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 165525
Corporate User License Price USD 7500
Corporate User License Price INR 496575
Site License Price USD 5000
Site License Price INR 331050
Request a Quote

Report Title

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015



Executive Summary

Hepatobiliary Disease Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Hepatobiliary Disease Global Clinical Trials Review, H1, 2015" provides data on the Hepatobiliary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatobiliary Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatobiliary Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Hepatobiliary Disease 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Clinical Trials by G7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials 12

Clinical Trials by Phase in G7 Countries 13

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by E7 Countries: Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Unaccomplished Trials of Hepatobiliary Disease 19

Subjects Recruited Over a Period of Time 20

Clinical Trials by Sponsor Type 21

Prominent Sponsors 22

Prominent Drugs 23

Clinical Trial Profiles 24

Clinical Trial Overview of Top Companies 24

Pfizer Inc. 24

Clinical Trial Overview of Pfizer Inc. 24

Clinical Trial Overview of Top Institutes / Government 25

Hiroshima University Hospital 25

Clinical Trial Overview of Hiroshima University Hospital 25

Hokkaido University Hospital 26

Clinical Trial Overview of Hokkaido University Hospital 26

Osaka University 27

Clinical Trial Overview of Osaka University 27

The University of Tokyo 28

Clinical Trial Overview of The University of Tokyo 28

Chiba University 29

Clinical Trial Overview of Chiba University 29

Guangdong Science and Technology Department 30

Clinical Trial Overview of Guangdong Science and Technology Department 30

Haydarpasa Numune State Hospital 31

Clinical Trial Overview of Haydarpasa Numune State Hospital 31

Hokkaido University School of Medicine 32

Clinical Trial Overview of Hokkaido University School of Medicine 32

Japanese Endoscopist & IVRists group for Biliary Tract Cancer 33

Clinical Trial Overview of Japanese Endoscopist & IVRists group for Biliary Tract Cancer 33

Kyoto Prefectural University of Medicine 34

Clinical Trial Overview of Kyoto Prefectural University of Medicine 34

Five Key Clinical Profiles 35

Appendix 49

Abbreviations 49

Definitions 49

Research Methodology 50

Secondary Research 50

About GlobalData 51

Contact Us 51

Disclaimer 51

Source 51

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 10

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20

Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

GlobalData Methodology 50

List of Tables

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Region, 2015* 6

Hepatobiliary Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Hepatobiliary Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Hepatobiliary Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10

Hepatobiliary Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 12

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Hepatobiliary Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Hepatobiliary Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 15

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Hepatobiliary Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Hepatobiliary Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Hepatobiliary Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19

Hepatobiliary Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 19

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20

Hepatobiliary Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22

Hepatobiliary Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 23

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 24

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* 25

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University Hospital, 2015* 26

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 27

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 28

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 29

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Science and Technology Department, 2015* 30

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Haydarpasa Numune State Hospital, 2015* 31

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hokkaido University School of Medicine, 2015* 32

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Endoscopist & IVRists group for Biliary Tract Cancer, 2015* 33

Hepatobiliary Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Hepatobiliary Disease Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatobiliary Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand